Prelude Therapeutics
Min Wang is an experienced professional in the field of life sciences, currently serving as a Director at Prelude Therapeutics after holding previous positions as Associate Director and Principal Scientist. Min Wang's academic journey includes a postdoctoral research role at the University of Massachusetts Medical School, preceded by educational accomplishments at Scripps Research from January 2012 to July 2014 and The University of New Mexico from 2005 to 2011.
This person is not in any teams
Prelude Therapeutics
3 followers
Prelude Therapeutics is a clinical-stage precision oncology company developing innovative drug candidates targeting critical cancer cell pathways.